US 10179912
RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
granted A61PA61P21/00A61P43/00
Quick answer
US patent 10179912 (RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P21/00, A61P43/00